genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2024
Wave Life Sciences
GEN Edge
StockWatch: Wave’s RNA Editing Milestone Lifts Korro, ProQR
Genome Editing
Wave Clinical Trial Shows First Successful RNA Editing in Humans
Drug Discovery
RNA Editing Therapy Developer Closes $60M Series A Financing
A-Lists
Top 10 Publicly Owned Gene Editing Therapy Companies
Drug Discovery
Frequency Change: Korro Bio Edits Its Message, Rewrites Its Future with Reverse Merger
Drug Discovery
Wave Life Sciences Reports Preclinical Proof of Concept for RNA Base Editing
Industry News
Pfizer, WAVE Life Sciences Launch Up-to-$911M+ Metabolic Disease Collaboration
Scroll Up
Scroll Up
